Business
Acquisition and Fundraising
Acquisition and Fundraising.
About this update from Cellbxhealth Plc
[{"type":"text","content":"\n \nRNS Number : 7506S Angle PLC 05 October 2017 \n\nTHIS ANNOUNCEMENT (INCLUDING THE APPENDIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL (\"RESTRICTED JURISDICTION\"). THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES. THE SECURITIES DISCUSSED HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE \"US SECURITIES ACT\") AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER THE US SECURITIES ACT. NO PUBLIC OFFERING OF THE SECURITIES DISCUSSED HEREIN IS BEING MADE IN THE UNITED STATES AND THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFERING OF SECURITIES FOR SALE IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.\n \nFURTHER, THIS ANNOUNCEMENT IS MADE FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR SOLICITATION TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE SHARES IN ANGLE PLC IN ANY JURISDICTION IN WHICH ANY SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL.\n \n5 October 2017\n \nANGLE plc \n(\"ANGLE\" or the \"Company\")\n \nProposed Placing of 29,437,152 New Ordinary Shares at 35 pence per share \nProposed subscriptions of 5,352,026 New Ordinary Shares at 35 pence per share\nConditional Acquisition of certain assets of Axela Inc. \n \n \nAcquisition expands ANGLE's liquid biopsy capabilities to enable 'sample to answer' capability\n \nANGLE plc (AIM:AGL OTCQX:ANPCY), a leading player in the liquid biopsy market, today announces the conditional acquisition of certain assets of Axela Inc. (\"Axela\") for a total consideration payable, subject to certain balancing adjustments, of CAD6.15 million (approximately £3.7 million) (the \"Acquisition\"), together with a conditional Placing and subscriptions (including a subscription by Covington, Axela's major shareholder and creditor) to raise in aggregate approximately £12.2 million (before expenses) at 35 pence (the \"Issue Price\") pe...